
    
      Initial doses will be given via sublingual route and a steady state trough level will be
      collected after 4 consecutive doses. Participants will then switched to oral tacrolimus, the
      dose adjusted for a goal trough 8-12ng/mL, and another steady state trough will be drawn.
    
  